Newsroom

Newsroom

Interclonal and intraclonal heterogeneity in patients with early myelodysplastic syndrome (MDS)

Literature
Read More

The role of molecular profiling of bone marrow samples in confirming the diagnosis of myelodysplastic syndrome in patients presenting with cytopenia

Literature
Read More

NeoGenomics Reports Revenue of $25.1 Million and Record Adjusted EBITDA of $2.8 Million Driven by a 25% Increase in Test Volume in the Third Quarter of 2015

Press Release
Read More

NeoGenomics Amends Strategic Alliance Agreement with Covance Central Laboratory Services

Press Release
Read More

NeoGenomics Signs Definitive Agreement to Acquire Clarient, Inc.

Press Release
Read More

NeoGenomics Schedules its Q3 2015 Earnings Release for October 29, 2015

Press Release
Read More

NeoGenomics Launches New NeoSITE™ Cervical FISH Assay for Evaluation of Abnormal Pap Tests

Press Release
Read More

NeoGenomics Enters into National Agreement with Premier, Inc. to Offer Cancer Genetics Testing Services to 3,600 Hospitals

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients